Royal London Asset Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$162M Buy
549,846
+1,111
+0.2% +$330K 0.34% 59
2025
Q4
$150M Buy
548,735
+11,495
+2% +$3.12M 0.32% 59
2025
Q3
$145M Sell
537,240
-8,091
-1% -$2.2M 0.31% 58
2025
Q2
$150M Sell
545,331
-7,258
-1% -$1.97M 0.34% 53
2025
Q1
$147M Buy
552,589
+59,048
+12% +$14.6M 0.35% 54
2024
Q4
$115M Buy
493,541
+1,207
+0.2% +$278K 0.28% 67
2024
Q3
$109M Buy
492,334
+34,475
+8% +$7.13M 0.27% 74
2024
Q2
$90M Sell
457,859
-13,952
-3% -$2.88M 0.23% 81
2024
Q1
$102M Buy
471,811
+52,487
+13% +$11M 0.25% 79
2023
Q4
$88.3M Buy
419,324
+32,732
+8% +$6.98M 0.25% 80
2023
Q3
$77.4M Buy
386,592
+58,230
+18% +$11.6M 0.25% 78
2023
Q2
$60.8M Buy
328,362
+78,822
+32% +$14.6M 0.2% 100
2023
Q1
$47.8M Buy
249,540
+14,713
+6% +$2.66M 0.19% 105
2022
Q4
$39.5M Buy
234,827
+4,064
+2% +$706K 0.18% 117
2022
Q3
$40.9M Sell
230,763
-5,786
-2% -$1.14M 0.21% 93
2022
Q2
$48.4M Sell
236,549
-3,442
-1% -$730K 0.22% 92
2022
Q1
$57.1M Buy
239,991
+3,198
+1% +$751K 0.22% 88
2021
Q4
$54.1M Sell
236,793
-17,024
-7% -$3.75M 0.2% 97
2021
Q3
$49.1M Buy
253,817
+2,889
+1% +$585K 0.2% 103
2021
Q2
$53.4M Sell
250,928
-8,879
-3% -$1.87M 0.22% 99
2021
Q1
$53.1M Sell
259,807
-8,120
-3% -$1.6M 0.24% 94
2020
Q4
$48.8M Buy
267,927
+8,990
+3% +$1.53M 0.26% 83
2020
Q3
$43M Buy
258,937
+35,532
+16% +$5.99M 0.26% 83
2020
Q2
$36.2M Buy
223,405
+2,394
+1% +$429K 0.25% 90
2020
Q1
$38.4M Buy
221,011
+77,555
+54% +$15.4M 0.31% 75
2019
Q4
$28.6M Buy
143,456
+794
+0.6% +$163K 0.2% 118
2019
Q3
$30.2M Sell
142,662
-2,361
-2% -$493K 0.23% 104
2019
Q2
$28.1M Sell
145,023
-2,211
-2% -$408K 0.27% 92
2019
Q1
$24.2M Sell
147,234
-3,050
-2% -$539K 0.19% 124
2018
Q4
$28M Buy
150,284
+14,613
+11% +$2.7M 0.24% 100
2018
Q3
$23.1M Sell
135,671
-5,169
-4% -$870K 0.24% 93
2018
Q2
$23.1M Buy
+140,840
New +$23M 0.23% 98
2016
Q2
$10.5M Sell
107,982
-7,384,824
-99% -$698M 0.17% 132
2016
Q1
$78K Buy
7,492,806
+7,378,851
+6,475% +$671M 0.11% 205
2015
Q4
$10.4M Buy
113,955
+688
+0.6% +$64.7K 0.16% 141
2015
Q3
$10.5M Buy
+113,267
New +$10.8M 0.17% 133
2014
Q4
$91.8K Buy
102,154
+25,138
+33% +$2.13M 0.17% 134
2014
Q3
$6.12M Buy
77,016
+3,740
+5% +$282K 0.15% 150
2014
Q2
$5.39M Sell
73,276
-330
-0.4% -$23.2K 0.12% 187
2014
Q1
$5.22M Sell
73,606
-2,044
-3% -$154K 0.12% 189
2013
Q4
$5.79M Sell
75,650
-2,249
-3% -$176K 0.15% 160
2013
Q3
$6M Buy
77,899
+567
+0.7% +$41.8K 0.16% 151
2013
Q2
$5.92M Buy
+77,332
New +$5.07M 0.17% 131

Other funds holding CME

Royal London Asset Management's CME Position: Q1 2026 in Review

Royal London Asset Management increased its CME Group (CME) stake by 0.2% in Q1 2026, buying an estimated $330K and bringing the position to 549,846 shares worth $162M. The position accounts for 0.34% of the portfolio, ranked #59.

Royal London Asset Management first reported a position in CME in Q2 2013 and has held it in 43 quarters since. 1,794 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Royal London Asset Management held 549,846 shares of CME Group worth $162M as of Q1 2026.
  • Royal London Asset Management bought 1,111 CME Group shares in Q1 2026, an estimated $330K.
  • CME Group made up 0.34% of Royal London Asset Management's portfolio in Q1 2026, its #59 holding.
  • Royal London Asset Management first reported a position in CME Group in Q2 2013 and has held it in 43 quarters since.
  • 1,794 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.